Contact
Please use this form to send email to PR contact of this press release:
Sandoz Canada receives Health Canada approval to launch two oncology biosimilars: Ziextenzo® and Riximyo®
TO:
Please use this form to send email to PR contact of this press release:
Sandoz Canada receives Health Canada approval to launch two oncology biosimilars: Ziextenzo® and Riximyo®
TO: